A plasma cell is a specialized B lymphocyte whose principal function is to synthesize and secrete antibodies, also called immunoglobulins. Plasma cells are effector cells of adaptive immunity: they produce the soluble recognition molecules that help defend against infection. They arise through differentiation of activated B cells rather than forming a separate developmental lineage. Mature plasma cells generally cease dividing, but remain highly active in antibody production. Some are short-lived, whereas others persist in supportive tissue environments and maintain antibody responses long after the initiating exposure. (nature.com)
Structure and identification
A typical mature plasma cell has abundant cytoplasm and an eccentrically positioned nucleus. Dense clumps of chromatin often form a characteristic “clock-face” or “cartwheel” pattern. A pale region beside the nucleus corresponds to the prominent Golgi apparatus. These features distinguish plasma cells from many resting lymphocytes in stained tissue sections. (ncbi.nlm.nih.gov)
The secretory apparatus is particularly well developed. Extensive rough endoplasmic reticulum supports immunoglobulin synthesis and processing, while the expanded cytoplasm accommodates sustained protein production. Plasma-cell differentiation therefore involves substantial changes in cellular architecture as well as function. (pmc.ncbi.nlm.nih.gov)
Human plasma cells commonly express high levels of CD38 and often CD138, also known as syndecan-1. These markers support identification by flow cytometry, but plasma-cell populations are heterogeneous. CD19 expression, for example, varies among bone-marrow subsets; both CD19-positive and CD19-negative populations can contain long-lived cells. No single surface-marker pattern establishes a cell’s lifespan by itself. (pmc.ncbi.nlm.nih.gov)
Formation during immune responses
Plasma-cell development begins when B cells receive activating signals associated with recognition of an antigen. In responses to many protein antigens, help from T cells supports B-cell proliferation and differentiation. Activated B cells can form antibody-secreting cells in extrafollicular regions of lymphoid tissues, providing an early antibody response, or enter a germinal center. (ncbi.nlm.nih.gov)
Within germinal centers, somatic hypermutation alters antibody variable-region genes. Selection favors cells whose receptors bind antigen effectively, producing affinity maturation. B-cell responses can also involve class-switch recombination, which changes the antibody heavy-chain constant region and its effector properties without replacing the rearranged variable-region sequence. Germinal-center descendants include both plasma cells and memory B cells. Plasma cells can nevertheless arise outside germinal centers, so germinal-center maturation is not a prerequisite for all antibody secretion. (pmc.ncbi.nlm.nih.gov)
Plasmablasts and mature plasma cells
A plasmablast is an antibody-secreting B-lineage cell that retains proliferative capacity. Plasmablasts frequently appear during active immune responses and can circulate before entering tissues. Mature plasma cells are generally non-dividing and exhibit a more fully developed secretory phenotype. The two categories describe related differentiation states rather than unrelated cell types. (pmc.ncbi.nlm.nih.gov)
Maturation and longevity are distinct properties. Becoming a mature plasma cell does not guarantee long-term persistence: survival also depends on cellular programs and access to suitable environmental signals. Consequently, “plasma cell” should not be treated as synonymous with “long-lived plasma cell.” (pmc.ncbi.nlm.nih.gov)
Molecular specialization
Differentiation involves extensive reorganization of gene expression. The transcription factors IRF4 and BLIMP-1, encoded by PRDM1, help establish the antibody-secreting state. BLIMP-1 suppresses important components of the earlier B-cell program while promoting functions needed for plasma-cell development and secretion. (pmc.ncbi.nlm.nih.gov)
Immunoglobulin production increases substantially, and processing of heavy-chain RNA favors transcripts encoding secreted rather than membrane-bound antibody. XBP1 helps coordinate the unfolded protein response and the secretory machinery needed to handle this output. This response supports protein processing and endoplasmic-reticulum function; in plasma cells, it forms part of physiological specialization rather than necessarily indicating pathological stress. (pmc.ncbi.nlm.nih.gov)
Tissue distribution and longevity
Plasma cells occur in lymphoid organs, mucosal tissues, and bone marrow. Long-lived bone-marrow populations occupy supportive microenvironments often called survival niches. Migration signals, cell adhesion, and locally supplied cytokines help regulate their residence and persistence. Survival reflects both intrinsic cellular adaptations and interactions with surrounding cells. (pmc.ncbi.nlm.nih.gov)
Human bone-marrow studies have identified plasma cells secreting antibodies against infections experienced more than 40 years earlier. Such findings support their contribution to immunological memory. Long-lived plasma cells continuously supply pre-existing antibodies, whereas memory B cells provide a reservoir capable of responding to renewed stimulation and generating additional antibody-secreting cells. These complementary functions distinguish persistent antibody production from recall responsiveness. (pmc.ncbi.nlm.nih.gov)
Antibody function and disease associations
Secreted antibodies act beyond the plasma cell itself. Depending on their specificity and class, they can neutralize pathogens or toxins, promote opsonization and uptake by phagocytes, or activate the complement system. Plasma cells supply these molecules; other cells and soluble components perform many of the resulting pathogen-clearance functions. (ncbi.nlm.nih.gov)
Abnormal clonal plasma-cell populations occur in several disorders. Multiple myeloma is a cancer characterized by malignant plasma cells accumulating in bone marrow. A localized plasma-cell tumor is termed a plasmacytoma. Monoclonal gammopathy of undetermined significance is not cancer, although it can precede a malignant plasma-cell disorder. These conditions may involve production of a monoclonal immunoglobulin or related protein, commonly called an M protein; their classification depends on laboratory, tissue, and clinical findings rather than the presence of plasma cells alone. (cancer.gov)